Apertus offers full service analysis per current USP/NF, ACS, JP/JPE, PhEur/PharmEuropa, AOAC, and DAB methodologies. Our experienced employees, comprehensive equipment capabilities, and efficient processes can help expedite the release of active pharmaceutical ingredients, excipients, and finished pharmaceutical products.
Apertus manufactures active pharmaceutical ingredients (APIs) for companies that make finished dosage products and/or develop novel dose delivery systems and formulations. Our focus is providing bulk controlled substance APIs, however non-controlled APIs are also within our project portfolio.
Methods Development and Deformulation
Apertus offers a complete package of services for your analytical development needs, from early stage research to fully validated methods for release testing. We provide rapid, customizable, cost-effective results that help you research, design and market your active ingredients, excipients or finished dosage forms.
Discovery Kilo Lab
Apertus provides synthetic services for drug discovery and preclinical development on a kilo-lab scale. We can supply intermediates, specialty chemical synthesis, process optimization and scale-up services. All services can be provided under cGMP if desired.